Hyperion Defi
Hyperion Defi's revenue rose 1318.8% to $1 million in fiscal 2025. Its operating margin was −5,743.5%, up from −85,004.6% a year earlier. The diluted share count rose 500.3%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on equity is net income as a share of shareholders' equity. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Hyperion Defi does
Hyperion DeFi, known until July 2025 as Eyenovia, holds a treasury of HYPE, the digital token of the Hyperliquid blockchain, and tries to earn money from it. Hyperliquid is a blockchain network that runs trading in cryptocurrency futures and other assets. The company says it gives its shareholders a simple way to own a stake in that network.
Most of its HYPE is staked, which means it is locked up to help run the network in return for rewards. In October 2025 the company set up a network validator, a computer that confirms transactions, called Kinetiq x Hyperion, with two partners; it receives 50% of the validator's commissions and rewards. At the end of 2025 it had about 939,074 HYPE staked directly to that validator. It also lends its tokens to other projects on the network for a share of their fees, and holds its tokens in its own digital wallets using outside custody services. It intends staking to become a main source of revenue.
The company still owns its earlier eye care business: the Optejet, a device that sprays a small dose of eye liquids such as artificial tears. It is completing the device's development and registration, and in early 2026 signed a non-binding letter of intent to sell or license it. It had nine employees at the end of 2025.
Its biggest risks, as it describes them
- Large losses if the price of HYPE falls, since its holdings are concentrated in that one token.
- Hyperliquid and HYPE are new, and could suffer technical failures, governance problems or competition from other blockchains.
- Losing tokens through stolen or lost keys, hacking, or flaws in the smart contracts it uses.
- HYPE could be treated as a security, or the company as an investment company, bringing rules that disrupt its plans.
- Its tokens are less easy to sell than cash, and staked tokens take seven days to unlock.
Income statement
Hyperion Defi lost money in fiscal 2025: a net loss of $45 million.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 20 | 23 | 15 | 2 | 6 |
| Debt incl. finance leases | 0 | 10 | 16 | — | — |
| Net debt (negative means net cash) | −20 | −12 | 1 | — | — |
| Net debt to EBITDA | — | — | — | — | — |
| Debt to equity | 0.0x | 0.6x | 1.7x | — | — |
| Interest coverage | −33.6x | −19.5x | −10.7x | −19.6x | −30.0x |
| Current ratio | 2.0x | 6.1x | 2.2x | 0.2x | 2.7x |
| Quick ratio | 2.0x | 6.1x | 2.2x | 0.2x | 2.7x |
Cash flow
Projections
Project Hyperion Defi's revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
What Hyperion Defi says to expect
- Full year 2026: adjusted gross profit
Guidance: We are reiterating our anticipated $7 million to $8 million Adjusted Gross Profit (1) in 2026, approximately 6x our 2025 FY results.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, 5 insiders bought $641,046 of Hyperion Defi shares on the open market, and none sold any.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Hyunsu JungSee Remarks, Director | Bought | 1,000 | $3.66 | $3,660 | Form 4 |
| Jun 1, 2026 | Hyunsu JungSee Remarks, Director | Bought | 7,000 | $3.70 | $25,920 | Form 4 |
| Dec 31, 2025 | David R. KnoxChief Financial Officer | Bought | 27,950 | $3.59 | $100,340 | Form 4 |
| Dec 29, 2025 | Ellen R StrahlmanDirector | Bought | 23,968 | $3.60 | $86,403 | Form 4 |
| Dec 26, 2025 | Ellen R StrahlmanDirector | Bought | 6,912 | $3.86 | $26,680 | Form 4 |
| Dec 18, 2025 | Ellen R StrahlmanDirector | Bought | 38,444 | $3.14 | $120,714 | Form 4 |
| Dec 17, 2025 | Happy David WaltersDirector | Bought | 61,930 | $3.02 | $187,029 | Form 4 |
| Dec 17, 2025 | Michael S GeltzeilerDirector | Bought | 30,000 | $3.01 | $90,300 | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | — | — | — |
| Rule of 40 | — | −51,401.8% | — |
| Altman Z'' | −19.39 | −287.46 | −16.62 |
| Accruals ratio | −11.4% | −121.4% | −110.2% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Fail | Fail | Fail |
| Cash from operations is positive | Fail | Fail | Fail |
| Return on assets rose | Pass | Fail | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Fail | — | — |
| Current ratio rose | Fail | Fail | Pass |
| Share count didn't rise | Pass | Fail | Fail |
| Gross margin rose | — | Fail | Pass |
| Revenue rose relative to assets | — | Pass | Pass |
| F-score | — | — | — |
Compare
Put Hyperion Defi side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Hyperion Defi | FY25 | 1,318.8% | −5,743.5% | — | — | — | — | |
| Nakamoto | FY25 | −33.0% | −10,824.0% | — | — | — | — | Compare |
| Bonk | FY25 | 201.6% | — | — | — | — | — | Compare |
| TAO Synergies | FY25 | — | −3,025.2% | — | — | — | — | Compare |
| Royalty Management Holding | FY25 | 513.3% | −5.9% | — | — | — | — | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | — | — | — | — | 2 | 14 | — | 0 | 0 | 1 |
| Revenue growth | — | — | — | — | — | 600.0% | — | — | 1,414.0% | 1,318.8% |
| Gross profit | — | — | — | — | 1 | 12 | — | −0 | −4 | 0 |
| Research and development | 3 | 4 | 11 | 14 | 13 | 15 | 13 | 13 | 14 | 2 |
| Operating income | −4 | −5 | −17 | −21 | −20 | −13 | −27 | −25 | −49 | −47 |
| Net income | −4 | −5 | −17 | −21 | −20 | −13 | −28 | −27 | −50 | −45 |
| Diluted EPS (US$) | −1.56 | −2.19 | −1.82 | −1.47 | −0.94 | −0.49 | −0.83 | −53.15 | −59.81 | −9.40 |
| Diluted shares (millions) | 2 | 2 | 10 | 14 | 21 | 26 | 34 | 0 | 1 | 5 |
| Cash flow | ||||||||||
| Cash from operations | −3 | −5 | −13 | −19 | −6 | −21 | −25 | −24 | −30 | −15 |
| Capital expenditure | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 3 | 0 | — |
| Free cash flow | −3 | −5 | −13 | −19 | −7 | −22 | −26 | −27 | −30 | — |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-based compensation | 0 | 0 | 2 | 2 | 2 | 3 | 4 | 2 | 2 | 6 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 3 | 5 | 20 | 14 | 28 | 20 | 23 | 15 | 2 | 6 |
| Debt incl. finance leases | — | — | — | 0 | 0 | 0 | 10 | 16 | — | — |
| Total assets | 3 | 6 | 20 | 15 | 34 | 32 | 31 | 29 | 4 | 52 |
| Total liabilities | 0 | 1 | 3 | 3 | 19 | 11 | 14 | 20 | 17 | 11 |
| Shareholders' equity | 3 | 5 | 17 | 12 | 15 | 20 | 17 | 9 | −13 | 41 |
| Margins and ratios | ||||||||||
| Gross margin | — | — | — | — | 60.0% | 88.6% | — | −322.6% | −6,749.5% | 62.7% |
| Operating margin | — | — | — | — | −989.5% | −93.0% | — | −670,885.8% | −85,004.6% | −5,743.5% |
| Net margin | — | — | — | — | −988.5% | −91.3% | — | −719,859.9% | −86,888.6% | −5,570.6% |
| Free cash flow margin | — | — | — | — | −332.3% | −157.9% | — | −704,624.5% | −52,815.8% | — |
| Rule of 40 (growth + FCF margin) | — | — | — | — | — | 442.1% | — | — | −51,401.8% | — |
| Return on capital | — | — | — | — | — | — | — | −275.3% | — | — |
| Return on equity | — | −126.7% | −157.1% | −147.9% | −146.2% | −71.5% | −148.6% | −207.8% | — | −324.1% |
| Return on assets | — | −113.0% | −134.5% | −121.9% | −81.3% | −39.0% | −89.4% | −91.2% | −307.1% | −163.5% |
| Net debt to EBITDA | — | — | — | — | — | — | — | — | — | — |